Kaléo

Kaléo is a commercial-stage biopharmaceutical company that develops patient‑centric therapeutics and drug‑delivery devices to empower patients and families to live fuller, bolder lives. It focuses on emergency care and other high‑impact therapies, and is known for device‑based products such as the Auvi‑Q epinephrine auto‑injector and naloxone rescue therapies. Kaléo combines clinical development, engineering, manufacturing and commercial capabilities to bring innovative solutions to market and partner across the healthcare ecosystem. Its mission, “Solutions for Life,” emphasizes meaningful, practical innovations that improve outcomes and daily living for patients.